Impact of Gene Patents and Licensing Practices on Access to Genetic Testing for Alzheimer Disease

Genetics in Medicine- United States

doi 10.1097/gim.0b013e3181d5a68e

Full Text

Abstract

Available in

Categories

Date

April 1, 2010

Authors

Christopher Heaney

Robert Cook-Deegan

Publisher

Springer Science and Business Media LLC

Related search

Impact of Gene Patents and Licensing Practices on Access to Genetic Testing for Long QT Syndrome

Genetics in Medicine

English

Impact of Gene Patents and Licensing Practices on Access to Genetic Testing and Carrier Screening for Tay-Sachs and Canavan Disease

Genetics in Medicine

English

Comment on the Impact of Gene Patents and Licensing Practices on Access to Genetic Testing: Lessons From Hereditary Hemorrhagic Telangiectasia

Genetics in Medicine

English

The Impact of Multiplex Genetic Testing on Disease Risk Perceptions

Clinical Genetics

English

University Licensing of Patents for Varietal Innovations in Agriculture

Agricultural Economics

English

Psychosocial Impact of Alzheimer Disease

JAMA - Journal of the American Medical Association

English

Use of Local Genetic Ancestry to Assess TOMM40-523′ and Risk for Alzheimer Disease

Neurology: Genetics

English

Patenting and Licensing in Genetic Testing: Ethical, Legal and Social Issues

European Journal of Human Genetics

English

Correction: Genetic Risk for Schizophrenia and Psychosis in Alzheimer Disease

Molecular Psychiatry

Molecular Neuroscience

Molecular Biology

English